Case Study: https://cdn-media.waldenu.edu/2dett4d/Walden/NURS/6630/DT/week_08/index.html

 

You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.

At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.

Introduction to the case (1 page)

• Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.

Decision #1 (1 page)

• Which decision did you select?
• Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
• Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Decision #2 (1 page)

• Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
• Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Decision #3 (1 page)

• Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
• What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
• Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Conclusion (1 page)

• Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature.

References to include:

 

• Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th Ed.) Cambridge University Press.
  • Chapter 13, “Impulsivity, Compulsivity, and Addiction” (pp. 538-578)

 

• Salmon, J. M., & Forester, B. (2012). Substance abuse and co-occurring psychiatric disorders in older adults: A clinical case and review of the relevant literature. Journal of Dual DiagnosisLinks to an external site., 8(1), 74–84. https://doi.org/10.1080/15504263.2012.648439

The group PPT should have a minimum of 20 slides and no more than 40 with speaker notes. (Including group members, outline, reference page). Reference and citations must be in APA format 6th or 7th Ed. 

The presentation should be directed to the pharmacological management of the disease. It should include the following: Drug indications, drug classification, generic name and most common brand name, mechanism of action, side effects, drug interactions, use of the drug in different populations and important pearls.

1: Title • Title: Understanding Anticoagulants 

• Subtitle: Essential Knowledge for Nurse Practitioners 

2: Introduction

• Brief overview of the importance of anticoagulants in healthcare. 

• Mention the aim of the presentation: to provide an understanding of different types of anticoagulants and their clinical applications. 

3: Blood Clotting Process 

• Explain the normal blood clotting process.

• Highlight the role of anticoagulants in preventing abnormal clot formation.

4: Types of Anticoagulants

• Detail the two main categories: Oral and Injectable anticoagulants.

• Mention common examples from each category. 

5: Oral Anticoagulants 

• Discuss commonly used oral anticoagulants like Warfarin, Apixaban, and Rivaroxaban.

• Emphasize their indications, dosages, and monitoring requirements.

6: Injectable Anticoagulants 

• Explain the use of injectable anticoagulants such as Heparin and Enoxaparin.

• Describe when and how these are administered. 

7: Novel Oral Anticoagulants (NOACs) 

• Highlight the benefits and considerations of NOACs like Apixaban and Rivaroxaban.

• Compare them to traditional anticoagulants. 

8: Monitoring and Safety 

• Discuss the importance of regular monitoring for anticoagulant therapy. 

• Address safety concerns, including bleeding risks. 

9: Reversal Agents 

• Explain the availability of reversal agents for anticoagulants. 

• Discuss their use in emergency situations. 

10: Patient Education 

• Provide key points for patient education regarding anticoagulant therapy.

• Emphasize compliance, dietary considerations, and recognizing signs of bleeding.

11: Conclusion 

• Summarize key takeaways from the presentation.

• Reiterate the importance of nurse practitioners’ role in managing anticoagulant therapy. 

12 Resources

• Provide references and recommended readings for further learning.

Explore the factors contributing to the development and recurrence of UTIs, such as urinary stasis, urinary catheterization, and antibiotic resistance. How can nurse practitioners assess and address these risk factors in patient care to prevent UTIs and minimize recurrence?